Unmatched* | Matched | |||||
---|---|---|---|---|---|---|
Levosimendan (n = 48) | Control (n = 128) | p | Levosimendan (n = 48) | Control (n = 78) | p | |
Variable (mean) | ||||||
Age (years) | 53.9 | 52.6 | 0.575 | 54.3 | 54.7 | 0.866 |
Male (%) | 62 | 65 | 0.692 | 0.62 | 0.65 | 0.785 |
Potential for recovery | 2.32 | 2.12 | 0.104 | 2.31 | 2.35 | 0.747 |
SAPS-II | 53.5 | 51.7 | 0.424 | 52.7 | 52.1 | 0.824 |
SOFA | 11.5 | 11.8 | 0.530 | 11.3 | 11.5 | 0.687 |
LVEF (%) | 18 | 20.2 | 0.241 | 18 | 17 | 0.690 |
VA-ECMO duration (days) | 10.6 | 6.5 | < 0.001 | 10.8 | 10.2 | 0.478 |
Serum lactate level (mmol/L) | 6.4 | 7.5 | 0.178 | 6.3 | 6.1 | 0.816 |